• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《延边地区韩籍华裔女性人乳头瘤病毒基因型特异性研究及疫苗引入系统》

A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region.

机构信息

Department of Pathology, College of Medicine, Kangwon National University, Chun-Cheon, Republic of Korea.

Department of Pathology, Yanbian Maternal and Child Health Care Hospital, Yanji, China.

出版信息

Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3331-3338. doi: 10.31557/APJCP.2020.21.11.3331.

DOI:10.31557/APJCP.2020.21.11.3331
PMID:33247692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033106/
Abstract

OBJECTIVES

Human papillomavirus (HPV) is a major cause of cervical cancer in women. The characteristics of HPV infection vary; therefore, it is necessary to identify the most common HPV genotypes among a group of subjects when introducing a vaccine program. Currently, in the Yanbian Autonomous Region, no HPV vaccinations are not provided, and no data has been reported regarding HPV rates or genotype prevalence. We aimed to find the most suitable HPV vaccine for this region and reasons why no vaccine has been introduced.

METHODS

HPV genotyping of 200 Korean-Chinese women living in the Yanbian Autonomous Region who visited the hospital for annual health examination was done. We also checked main factors necessary for HPV vaccine administrative system; (1) vaccine manufacturers in China, (2) vaccine importers, (3) vaccine suppliers, (4) applicable vaccine laws, (5) the HPV vaccine permit system in Jilin Province, and (6) vaccination hospital facilities-were assessed by direct inquiry and search.

RESULTS

The results showed that HPV genotypes 52, 58, 16, 53, and 33 were the most common among Korean-Chinese women. These results differed from those previously reported for Korean or Chinese women. All elements necessary for introduction of HPV vaccine were prepared, but there is no HPV vaccination plan based on epidemiological investigation.

CONCLUSIONS

Gardasil® 9 should be the most suitable vaccine for Korean-Chinese women with HPV infection and cervical cancer in this region considering the prevalence of certain genotypes. Governments and medical institutions should take an active stance on HPV vaccination to lower the incidence of cervical cancer here. Our study may serve as an important reference for introducing a Chinese government program designed to prevent cervical cancer.

摘要

目的

人乳头瘤病毒(HPV)是导致女性宫颈癌的主要原因。HPV 感染的特征各不相同;因此,在引入疫苗计划时,有必要确定一组研究对象中最常见的 HPV 基因型。目前,在延边朝鲜族自治州,没有提供 HPV 疫苗接种,也没有报告 HPV 率或基因型流行率的数据。我们旨在为该地区找到最合适的 HPV 疫苗,并探讨为什么没有引入疫苗的原因。

方法

对在延边朝鲜族自治州因年度健康检查而就诊的 200 名韩裔中国女性进行 HPV 基因分型。我们还检查了 HPV 疫苗管理系统所需的主要因素;(1)中国的疫苗制造商,(2)疫苗进口商,(3)疫苗供应商,(4)适用的疫苗法律,(5)吉林省 HPV 疫苗许可制度,(6)接种医院设施,通过直接询问和搜索进行了评估。

结果

结果显示,HPV 基因型 52、58、16、53 和 33 是韩裔中国女性中最常见的类型。这些结果与之前报道的韩国或中国女性的结果不同。引入 HPV 疫苗的所有必要因素都已准备就绪,但没有基于流行病学调查的 HPV 疫苗接种计划。

结论

考虑到某些基因型的流行率,加卫苗 9 应该是该地区 HPV 感染和宫颈癌韩裔中国女性最适合的疫苗。政府和医疗机构应积极采取行动,以降低该地区宫颈癌的发病率。我们的研究可能为引入旨在预防宫颈癌的中国政府计划提供重要参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/d927c350c402/APJCP-21-3331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/12107ae88d32/APJCP-21-3331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/4146be8a5859/APJCP-21-3331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/a417dcccc372/APJCP-21-3331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/d927c350c402/APJCP-21-3331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/12107ae88d32/APJCP-21-3331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/4146be8a5859/APJCP-21-3331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/a417dcccc372/APJCP-21-3331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac0/8033106/d927c350c402/APJCP-21-3331-g004.jpg

相似文献

1
A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region.《延边地区韩籍华裔女性人乳头瘤病毒基因型特异性研究及疫苗引入系统》
Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3331-3338. doi: 10.31557/APJCP.2020.21.11.3331.
2
Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.在澳大利亚实施全国性疫苗接种计划后,评估年轻澳大利亚女性中生殖器人乳头瘤病毒的基因型流行情况。
Vaccine. 2015 Jan 1;33(1):201-8. doi: 10.1016/j.vaccine.2014.10.045. Epub 2014 Nov 1.
3
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.人乳头瘤病毒在俄罗斯联邦、前苏联西方国家、高加索地区和中亚的流行情况和型别分布、宫颈癌筛查实践以及疫苗接种实施现状。
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
4
Impact of HPV vaccination with Gardasil® in Switzerland.瑞士加德西®(Gardasil®)人乳头瘤病毒疫苗的影响。
BMC Infect Dis. 2017 Dec 22;17(1):790. doi: 10.1186/s12879-017-2867-x.
5
Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development.高危韩国女性人乳头瘤病毒感染及基因型分布的流行情况,为疫苗开发策略提供依据。
Virol J. 2010 Aug 25;7:201. doi: 10.1186/1743-422X-7-201.
6
Characteristics of carcinogenic human papillomavirus infection in Suzhou: Epidemiology, vaccine evaluation, and associated diseases.苏州地区人乳头瘤病毒致癌特征:流行病学、疫苗评估及相关疾病。
J Med Virol. 2017 May;89(5):895-901. doi: 10.1002/jmv.24700. Epub 2016 Oct 17.
7
HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.在中国吉林省,HPV 基因型谱显示出双峰年龄特异性模式,其中非疫苗覆盖的 HPV53 和 51 型较为流行。
PLoS One. 2020 Mar 24;15(3):e0230640. doi: 10.1371/journal.pone.0230640. eCollection 2020.
8
Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.接种疫苗后澳大利亚原住民妇女人乳头瘤病毒感染流行率下降,该人群宫颈癌风险更高:VIP-I 研究。
Vaccine. 2018 Jul 5;36(29):4311-4316. doi: 10.1016/j.vaccine.2018.05.104. Epub 2018 Jun 5.
9
Prevalence of high-risk HPV and its genotypes-Implications in the choice of prophylactic HPV vaccine.高危型 HPV 及其基因型的流行情况-对预防性 HPV 疫苗选择的影响。
J Med Virol. 2021 Aug;93(8):5188-5192. doi: 10.1002/jmv.27015. Epub 2021 Apr 23.
10
HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer.人乳头瘤病毒基因型流行率及预防宫颈癌疫苗接种的成效
Acta Cytol. 2020;64(5):420-424. doi: 10.1159/000506725. Epub 2020 Apr 1.

本文引用的文献

1
The Changes in the Awareness of Cervical Cancer Prevention and the Acceptability of HPV Vaccines among Women after Their Introduction in China.中国引入宫颈癌预防意识及HPV疫苗后女性对其接受度的变化
Biomed Environ Sci. 2019 Nov;32(11):864-868. doi: 10.3967/bes2019.109.
2
Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.韩国人乳头瘤病毒(HPV)相关疾病负担及HPV疫苗的潜在影响。
Papillomavirus Res. 2019 Jun;7:26-42. doi: 10.1016/j.pvr.2018.12.002. Epub 2018 Dec 30.
3
HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
与宫颈癌相关的人乳头瘤病毒基因型共感染:特别关注系统发育相关和非疫苗靶向基因型。
PLoS One. 2017 Nov 21;12(11):e0187844. doi: 10.1371/journal.pone.0187844. eCollection 2017.
4
The natural history of human papillomavirus infection.人类乳头瘤病毒感染的自然史。
Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:2-13. doi: 10.1016/j.bpobgyn.2017.08.015. Epub 2017 Sep 6.
5
Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings.韩国13个城市18815名女性的人乳头瘤病毒基因型分布及其与宫颈细胞学检查结果的关系
Ann Lab Med. 2017 Sep;37(5):426-433. doi: 10.3343/alm.2017.37.5.426.
6
Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea.韩国968名女性中人乳头瘤病毒的流行情况及类型分布
J Cancer Prev. 2016 Jun;21(2):104-9. doi: 10.15430/JCP.2016.21.2.104. Epub 2016 Jun 30.
7
Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies.中国对人乳头瘤病毒疫苗的认知、知识及接受度:58项观察性研究的荟萃分析
BMC Public Health. 2016 Mar 3;16:216. doi: 10.1186/s12889-016-2873-8.
8
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
9
Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.中国37个城市人乳头瘤病毒感染的全国患病率及病毒基因型分布
BMC Infect Dis. 2015 Jul 4;15:257. doi: 10.1186/s12879-015-0998-5.
10
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.九价人乳头瘤病毒(HPV)疫苗的使用:免疫实践咨询委员会的HPV疫苗接种最新建议
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4.